Trial intelligence / Profile preview

Methylphenidate for Emergence from Isoflurane Anesthesia

NCT02327195Phase 1Completed

Start
May 2014
Primary completion
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of methylphenidate hydrochloride extended-release chewable tablet in delayed emergence from anesthesia (2 arms). Primary endpoint: Time to Emergence from Anesthesia. Started May 2014; status: completed.

02

Drugs

methylphenidate hydrochloride extended-release chewable tablet
03

Conditions

delayed emergence from anesthesia

Beyond the preview

Go deeper on NCT02327195.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02327195.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call